Details of Experiment

Regulating Pair
Introduced Variation	Inhibition (YC-1) of HIF1A	Protein Info
Induced Change	Glucose concentration: decrease	Metabo Info
Summary	Introduced Variation Induced Change

Full List of Experiment(s) Validating This Regulating Pair
Details of Experiment for Validating This Pair			[1]
Method	Quantifying the change of D-glucose concentration after HIF1A inhibition through kit detection.
Disease Status	Hepatocellular carcinoma	ICD-11: 2C12
Organ/Tissue/Cell Line	HepG2 cells (Human hepatoma cells)	Liver
	Hep3B (Human hepatoma cells)	Liver
	THLE3 cells (Primary normal liver cells)	Liver
Subcellular Location	Cytoplasm; Nucleus (Nucleus speckle)
Tested Species	Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) Kingdom: Metazoa Phylum: Chordata Class: Mammalia Order: Primates Family: Hominidae Genus: Homo Species: Homo sapiens
Details	It is reported that inhibition of HIF1A leads to the decrease of glucose levels compared with control group in HepG2 cells, Hep3B and THLE3 cells.

References
1	Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1-dependent and -independent mechanism. PLoS One. 2017 Sep 8;12(9):e0184213.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.